Tetraphase Pharmaceu (TTPH) Stock Price, Forecast & Analysis

NASDAQ:TTPH

2.2
-0.08 (-3.51%)
At close: Jul 28, 2020
2.31
+0.11 (+5%)
After Hours: 7/28/2020, 8:00:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

TTPH Key Statistics, Chart & Performance

Key Statistics
Market Cap15.98M
Revenue(TTM)7.86M
Net Income(TTM)-62.72M
Shares7.26M
Float2.02M
52 Week High8.6
52 Week Low0.56
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-18.46
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
TTPH short term performance overview.The bars show the price performance of TTPH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

TTPH long term performance overview.The bars show the price performance of TTPH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of TTPH is 2.2 null. In the past month the price decreased by -14.73%. In the past year, price decreased by -68.12%.

Tetraphase Pharmaceu / TTPH Daily stock chart

TTPH Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to TTPH. When comparing the yearly performance of all stocks, TTPH is a bad performer in the overall market: 64.88% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
TTPH Full Technical Analysis Report

TTPH Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TTPH. Both the profitability and financial health of TTPH have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TTPH Full Fundamental Analysis Report

TTPH Financial Highlights

Over the last trailing twelve months TTPH reported a non-GAAP Earnings per Share(EPS) of -18.46. The EPS decreased by -126.5% compared to the year before.


Industry RankSector Rank
PM (TTM) -798.18%
ROA -167.91%
ROE N/A
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%81.81%
Sales Q2Q%37.86%
EPS 1Y (TTM)-126.5%
Revenue 1Y (TTM)-57.03%
TTPH financials

TTPH Forecast & Estimates


Analysts
Analysts40
Price TargetN/A
EPS Next Y82.71%
Revenue Next YearN/A
TTPH Analyst EstimatesTTPH Analyst Ratings

TTPH Ownership

Ownership
Inst Owners0%
Ins Owners84.11%
Short Float %N/A
Short RatioN/A
TTPH Ownership

About TTPH

Company Profile

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.

Company Info

Tetraphase Pharmaceu

480 ARSENAL WAY

WATERTOWN MA 02472

CEO: Larry Edwards

Phone: 617-715-3600

Tetraphase Pharmaceu / TTPH FAQ

Can you describe the business of Tetraphase Pharmaceu?

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.


What is the stock price of Tetraphase Pharmaceu today?

The current stock price of TTPH is 2.2 null. The price decreased by -3.51% in the last trading session.


Does Tetraphase Pharmaceu pay dividends?

TTPH does not pay a dividend.


How is the ChartMill rating for Tetraphase Pharmaceu?

TTPH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is Tetraphase Pharmaceu worth?

Tetraphase Pharmaceu (TTPH) has a market capitalization of 15.98M null. This makes TTPH a Nano Cap stock.